BOLT · Bolt Biotherapeutics, Inc. · Exempt Offerings
$3.45
-0.06 (-1.71%)
At close · Oct 2
Return incl. dividend (before tax)
Going-concern doubt
— flagged Aug 11, 2026
Substantial doubt about the company's ability to continue as a going concern.
“The Company believes that this raises substantial doubt about its ability to continue as a going concern within one year after the issuance of the unaudited condensed consolidated financial statements.”View the 10-Q filed Aug 11, 2026
Market Cap
$6.93M
Shares
1.93M
Volume · Oct 2
885
Avg daily vol (3M)
25.46K
Private capital raises reported to the SEC on Form D under Regulation D, showing the offering size, amount sold, minimum investment and number of investors. Public operating companies rarely raise capital this way, so this page is often empty.